Stephen Wood
OTHER
INVESTOR TYPE
Active
STATUS
2
INVESTMENTS
1
PORTFOLIO
1
EXITS
Description
Mr. Stephen Wood serves as Director at Pentraxin Therapeutics.
Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel (individual)
Primary Office
- Wolfson Drug Discovery Unit Centre for Amyloidosis and Acute Phase Proteins
- Division of Medicine, Royal Free Campus, University College London, Rowland Hill Street
- London NW3 2PF
- England, United Kingdom
Stephen Wood Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Ffrees | 24-Oct-2014 | Early Stage VC | 00.000 | Other Commercial Banks | Bankruptcy: Admin/Reorg | 0000000 0000 |
| 000000000 00000000 | 00000 00000 | Drug Discovery | Generating Revenue | 0000000 0000 |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Stephen Wood’s full profile, request a free trial.
Stephen Wood Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 000000 | 29-Mar-2019 | 0000000000: 000000 | Completed |
|